CSL Stock Analysis: Carlisle Companies | NYSE
Building Products & Equipment | NYSE, USA | Market Cap: 14.857m USD | 12M Return: -17.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 194M
EPS Trend: 78.7%
Qual. Beats: 0
Rev. Trend: 29.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Carlisle Companies Incorporated (NYSE: CSL) is a manufacturer and supplier of building envelope products and solutions, operating across the United States, Europe, North America, and other international markets. The company is structured around two segments: Carlisle Construction Materials (CCM), which produces single-ply roofing membranes (EPDM, TPO, PVC), polyiso insulation, and engineered metal roofing and wall systems; and Carlisle Weatherproofing Technologies (CWT), which offers waterproofing products, air/vapor barriers, roof coatings, sealants, spray polyurethane foam, and other protective solutions. Demand in this sector is closely tied to commercial construction starts, re-roofing cycles, and non-residential building activity.
Carlisle sells its products under brands including Carlisle SynTec, Versico, WeatherBond, Hunter Panels, Resitrix, and Hertalan. The company was founded in 1917 and is headquartered in Scottsdale, Arizona.
- Commercial construction demand drives single-ply roofing volumes
- Raw material costs pressure Construction Materials segment margins
- Residential housing market exposure lifts Weatherproofing Technologies segment
| Net Income: 725.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 1.52 > 1.0 |
| NWC/Revenue: 28.76% < 20% (prev 18.76%; Δ 10.00% < -1%) |
| CFO/TA 0.18 > 3% & CFO 1.05b > Net Income 725.1m |
| Net Debt (2.21b) to EBITDA (1.23b): 1.80 < 3 |
| Current Ratio: 3.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.1m) vs 12m ago -8.05% < -2% |
| Gross Margin: 35.57% > 18% (prev 37.47%; Δ -1.90% > 0.5%) |
| Asset Turnover: 86.99% > 50% (prev 91.78%; Δ -4.79% > 0%) |
| Interest Coverage Ratio: 11.18 > 6 (EBIT TTM 1.03b / Interest Expense TTM 92.0m) |
| A: 0.24 (Total Current Assets 2.03b - Total Current Liabilities 601.3m) / Total Assets 5.99b |
| B: 1.24 (Retained Earnings 7.41b / Total Assets 5.99b) |
| C: 0.18 (EBIT TTM 1.03b / Avg Total Assets 5.72b) |
| D: 0.38 (Book Value of Equity 1.65b / Total Liabilities 4.34b) |
| Altman-Z'' = 7.21 = AAA |
| DSRI: 0.99 (Receivables 692.1m/699.4m, Revenue 4.98b/5.00b) |
| GMI: 1.05 (GM 37.47% / 35.57%) |
| AQI: 0.90 (AQ_t 0.52 / AQ_t-1 0.58) |
| SGI: 0.99 (Revenue 4.98b / 5.00b) |
| TATA: -0.05 (NI 725.1m - CFO 1.05b) / TA 5.99b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of July 15, 2026, the stock is trading at USD 338.35 with a total of 285,498 shares traded. Over the past week, the price has changed by -4.39%, over one month by -4.30%, over three months by -5.10% and over the past year by -17.39%.
Current recommended Stop Loss: 315.00 (which is 6.9% or 1.6 ATR below the current price).
Carlisle Companies has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CSL.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 410.1 | 21.2% |
P/E Trailing = 21.4332
P/E Forward = 17.5131
P/S = 2.9856
P/B = 8.9764
P/EG = 1.1681
Revenue TTM = 4.98b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.23b USD
Long Term Debt = 2.88b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.98b USD (from shortLongTermDebtTotal, last quarter) + Leases 100.5m
Net Debt = 2.21b USD (calculated: Debt 2.98b - CCE 771.3m)
Enterprise Value = 17.1b USD (14.9b + Debt 2.98b - CCE 771.3m)
Interest Coverage Ratio = 11.18 (Ebit TTM 1.03b / Interest Expense TTM 92.0m)
EV/FCF = 18.46x (Enterprise Value 17.1b / FCF TTM 924.8m)
FCF Yield = 5.42% (FCF TTM 924.8m / Enterprise Value 17.1b)
FCF Margin = 18.58% (FCF TTM 924.8m / Revenue TTM 4.98b)
Net Margin = 14.57% (Net Income TTM 725.1m / Revenue TTM 4.98b)
Gross Margin = 35.57% ((Revenue TTM 4.98b - Cost of Revenue TTM 3.21b) / Revenue TTM)
Gross Margin QoQ = 34.52% (prev 33.75%)
Tobins Q-Ratio = 2.85 (Enterprise Value 17.1b / Total Assets 5.99b)
Interest Expense / Debt = 3.08% (Interest Expense 92.0m / Debt 2.98b)
Taxrate = 22.08% (206.9m / 937.0m)
NOPAT = 801.8m (EBIT 1.03b * (1 - 22.08%))
Current Ratio = 3.38 (Total Current Assets 2.03b / Total Current Liabilities 601.3m)
Debt / Equity = 1.81 (Debt 2.98b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 1.80 (Net Debt 2.21b / EBITDA 1.23b)
Debt / FCF = 2.39 (Net Debt 2.21b / FCF TTM 924.8m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.68% (Net Income 725.1m / Total Assets 5.99b)
RoE = 38.36% (Net Income TTM 725.1m / Total Stockholder Equity 1.89b)
RoCE = 21.55% (EBIT 1.03b / Capital Employed (Equity 1.89b + L.T.Debt 2.88b))
RoIC = 15.60% (NOPAT 801.8m / Invested Capital 5.14b)
WACC = 8.64% (E(14.9b)/V(17.8b) * Re(9.89%) + D(2.98b)/V(17.8b) * Rd(3.08%) * (1-Tc(0.22)))
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.36 | Cagr: -7.43%
[DCF] Terminal Value 77.04% ; FCFF base≈858.4m ; Y1≈984.0m ; Y5≈1.45b
[DCF] Fair Price = 458.0 (EV 20.7b - Net Debt 2.21b = Equity 18.5b / Shares 40.5m; r=8.64% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 78.74 | EPS CAGR: 7.12% | SUE: 0.81 | # QB: 0
Revenue Correlation: 29.87 | Revenue CAGR: 0.97% | SUE: -0.22 | # QB: 0
EPS current Quarter (2026-06-30): EPS=6.42 | Chg30d=-0.43% | Revisions=-40% | Analysts=9
EPS next Quarter (2026-09-30): EPS=6.42 | Chg30d=+0.14% | Revisions=+0% | Analysts=9
EPS current Year (2026-12-31): EPS=20.94 | Chg30d=-0.05% | Revisions=-40% | GrowthEPS=+8.0% | GrowthRev=+2.5%
EPS next Year (2027-12-31): EPS=23.44 | Chg30d=-0.01% | Revisions=-40% | GrowthEPS=+11.9% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: -55% (up=1, down=7)